Graham Jonathan P 4
4 · AMGEN INC · Filed Mar 18, 2026
Research Summary
AI-generated summary of this filing
Amgen EVP Jonathan P. Graham Sells 5,353 Shares
What Happened
Jonathan P. Graham, Executive Vice President, General Counsel & Secretary of Amgen (AMGN), had 5,353 shares disposed on March 16, 2026 to satisfy tax withholding related to equity compensation. The shares were disposed at $366.21 each for a total of approximately $1,960,322. This transaction reflects tax withholding on vested awards rather than an open-market purchase for investment.
Key Details
- Transaction date: 2026-03-16; filing date: 2026-03-18 (filed within the usual reporting window).
- Disposed: 5,353 shares at $366.21 per share; total value ~$1,960,322.
- Footnote: 659 of these shares were Dividend Equivalents (DEs) credited to unvested Restricted Stock Units and paid out in shares per the Amgen 2009 Equity Incentive Plan. Fractional share amounts are paid in cash.
- Transaction code: F (payment of exercise price or tax liability / withholding).
- Shares owned after the transaction: not specified in the provided filing.
Context
This was a routine tax-withholding disposal tied to equity compensation vesting (including DEs). Such disposals are administrative and do not necessarily indicate an insider's view on the company's stock. Purchases by insiders typically carry more informational weight for investors than withholding or sale transactions.
Insider Transaction Report
- Tax Payment
Common Stock
[F1]2026-03-16$366.21/sh−5,353$1,960,322→ 39,267 total
Footnotes (1)
- [F1]These shares include 659 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.